ADMA vs DOW · P/E 22, rev $238.9M vs P/E 74, rev $39.97B
ADMA Biologics Inc (ADMA) versus Dow Inc (DOW) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Dow Inc (DOW) is a chemicals company listed on US.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Not investment advice. Open the ADMA and DOW stock pages for the full models.
Not investment advice.